H-LLFGYPVYV-OH
Ref. 3D-PP40518
1mg | 217,00 € | ||
10mg | 253,00 € | ||
100mg | 455,00 € |
Información del producto
- NH2-Leu-Leu-Phe-Gly-Tyr-Pro-Val-Tyr-Val-OH
Peptide H-LLFGYPVYV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LLFGYPVYV-OH include the following: Copyright zyxwvutsrqponmlkjihgfedcb Y Sauma - J Immunol, 1993 - academia.eduhttps://www.academia.edu/download/108466258/1763.pdf Structure-activity mapping of the peptide-and force-dependent landscape of T-cell activation Y Feng , X Zhao, AK White , KC Garcia , PM Fordyce - Biorxiv, 2021 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2021.04.24.441194.abstract The structural basis for the increased immunogenicity of two HIV-reverse transcriptase peptide variant/class I major histocompatibility complexes TJ Kirksey, RR Pogue-Caley, JA Frelinger - Journal of Biological , 1999 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)53086-1/abstract Her-2/neu altered peptide ligand-induced CTL responses: implications for peptides with increased HLA affinity and T-cell-receptor interaction SO Dionne, CE Myers, MH Smith, DF Lake - Cancer Immunology , 2004 - Springerhttps://link.springer.com/article/10.1007/s00262-003-0439-y Epitope Prediction Algorithms for Class I MHC Molecules RG Urban, RM Chicz, KC Parker - MHC Molecules: Expression, Assembly , 1996 - Springerhttps://link.springer.com/chapter/10.1007/978-1-4684-6462-7_10 Genome-wide Screening of Human Papillomavirus-Specific CTL Epitopes Presented by HLA-A Alleles in Cervical Cancer QH Wang, XY Gao, XL Lou, L Yao, ZX Zhang - Journal of Peptide , 2016 - Springerhttps://link.springer.com/article/10.1007/s10989-015-9480-x Applying generalized hydrophobicity scale of amino acids to quantitative prediction of human leukocyte antigen-A* 0201-restricted cytotoxic T lymphocyte epitope P Zhou , F Tian, M Zhang , Z Li - Chinese Science Bulletin, 2006 - Springerhttps://link.springer.com/article/10.1007/s11434-006-1439-z Quantifying and Imaging P Vyas, JL Chen , V Cerundolo, BK Karbach, E Jager - J Immunol, 2006 - academia.eduhttps://www.academia.edu/download/68505824/7308.full.pdf T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility OY Borbulevych , KH Piepenbrink , BE Gloor, DR Scott - Immunity, 2009 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(09)00498-1.pdf MHC Class I Molecules with NA CTLs, SCD Binding - J. Immunol, 2010 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=f8202eb4619e178604accb92076d32557c5daa64 Peptide binding by class I and class II MHC molecules MA Batalia, EJ Collins - Peptide Science, 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0282(1997)43:4%3C281::AID-BIP3%3E3.0.CO;2-R Human rhinovirus-specific CD8 T cell responses target conserved and unusual epitopes M Gomez-Perosanz , JL Sanchez-Trincado - The FASEB , 2021 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753581/ Antigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex M Bouvier, DC Wiley - of the National Academy of Sciences, 1996 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.93.10.4583 On Conformations of Peptides Bound to Class I Major Histocompatibility Complexes J Wang, BY Chen - Proceedings of the 10th ACM International , 2019 - dl.acm.orghttps://dl.acm.org/doi/abs/10.1145/3307339.3343868 Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. HJ Zweerink, MC Gammon, U Utz - (Baltimore, Md.: 1950 , 1993 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/150/5/1763/25828 Dynamic Flexibility of a Peptide-Binding Groove of Human HLA-DR1 Class II MHC Molecules: Normal Mode Analysis of the Antigen Peptide-Class II MHC Complex H Nojima, M Takeda-Shitaka, Y Kurihara - Chemical and , 2003 - jstage.jst.go.jphttps://www.jstage.jst.go.jp/article/cpb/51/8/51_8_923/_article/-char/ja/ A general and efficient approach for NMR studies of peptide dynamics in class I MHC peptide binding grooves FK Insaidoo, J Zajicek, BM Baker - Biochemistry, 2009 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi9008787 Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cells C Douat-Casassus, N Marchand-Geneste - Journal of medicinal , 2007 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jm0613368 The structure and stability of an HLA-A* 0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site AR Khan , BM Baker , P Ghosh, WE Biddison - The Journal of , 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/164/12/6398/33064
Propiedades químicas
Consulta técnica sobre: 3D-PP40518 H-LLFGYPVYV-OH
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.